Dennis Hulme

Dennis Hulme is a seasoned analyst in the biotech and healthcare sectors, currently serving as a Biotech/Healthcare Analyst at Taylor Collison Limited since August 2019, and as a Senior Healthcare Analyst and Director of Healthcare at Edison Group since November 2014. With extensive experience in the healthcare industry, Dennis held the position of Senior Healthcare & Industrials Analyst at BBY Limited from May 2005 to November 2014. Earlier roles include serving as a Clinical Analyst at the UK Ministry of Agriculture, conducting epidemiological investigations, and as a Senior Research Scientist at the University of Sydney, contributing to significant genetic research supported by NHMRC grants. Dennis's academic qualifications include a Doctor of Philosophy in Immunogenetics from the University of Sydney, along with degrees in Applied Valuation, Computing, and Veterinary Science.